Basic Information
Basic information for LINC02223-219-32aa
Peptide Name LINC02223-219-32aa
Genome Position chr5:17929575-17929670[+]
Species Human
Peptide Sequence MSICILKSTSLASNRPELRSNSLIYLCCFLFP
Peptide Length 32
Unique No (LINC02223-205-32aa,LINC02223-206-32aa,LINC02223-207-32aa,LINC02223-208-32aa,LINC02223-212-32aa,LINC02223-213-32aa,LINC02223-214-32aa,LINC02223-215-32aa,LINC02223-216-32aa)
Grand Average of Hydropathicity 0.6156
Relative Molecular Mass 4179.8
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000249937;LINC02223
Transcript ID/Name ENST00000670782;LINC02223-219
Transcript Length 1596
Coding Ability 0.4392
DNA Sequence Corresponding to Peptide ATGTCAATTTGTATTCTTAAGAGCACAAGTTTGGCCTCAAATAGACCTGAGCTGAGATCCAATTCTTTAATTTATCTGTGTTGTTTTCTTTTTCCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :